MPowrx™ launches e-Book to help parents recognize their children’s sleep health issues The health risks for children with sleep-disordered breathing is far worse than a simply a poor night’s sleep. Approximately 9 million children in the United States have sleep-disordered breathing and as many as 4 million children have obstructive sleep apnea. MPowrx™, leaders in .. read more
Calgary based MPowrx™ iSleepSound™ inventor and sleep researcher Dr. Leslie Dort, alongside CPAP inventor and sleep researcher Dr. John Remmers, recently published a paper in the Journal of Clinical Sleep Medicine. In this study, it was concluded that a combined approach utilizing both mandibular protrusion and tongue retention devices like MPowrx™’s appliance can provide effective .. read more
Calgary-based MPowRx Health and Wellness Products Inc. announced that the United States Patent and Trademark Office has granted United States Patent 7,946,292 entitled “Tongue Retention Device”. The awarded Patent broadly covers the MPowRx™ Snoring Solution and underscores the innovative nature of the device. This Patent complements a previously awarded US Patent 7,533,674 entitled “Tongue Retention .. read more
Calgary-based MPowRx Health and Wellness Products announced that the Australian Therapeutic Goods Administration (ATGA) has reviewed, cleared and granted the company permission to market, sell and distribute its anti-snoring appliance in Australia.
Calgary-based MPowRx Health and Wellness Products Inc. announced that the European Commission and sanctioned notified bodies have reviewed and cleared an application in accordance with the medical device directive 93/42. MPowRx is granted permission to market, sell and distribute its’ Anti Snoring Appliance in all 27 EU member states.